Back to top
more

DBV Technologies (DBVT)

(Real Time Quote from BATS)

$8.71 USD

8.71
18,289

-0.29 (-3.22%)

Updated Aug 4, 2025 03:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last?

by Zacks Equity Research

Cartesian Therapeutics, Inc. (RNAC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks Equity Research

Is CoreCard (CCRD) Stock Outpacing Its Business Services Peers This Year?

by Zacks Equity Research

Here is how CoreCard Corporation (CCRD) and Global Blue Group Holding AG (GB) have performed compared to their sector so far this year.

Zacks Equity Research

Are Finance Stocks Lagging Royal Bank Of Canada (RY) This Year?

by Zacks Equity Research

Here is how Royal Bank (RY) and Acadian Asset Management (AAMI) have performed compared to their sector so far this year.

Zacks Equity Research

Are Utilities Stocks Lagging E.ON (EONGY) This Year?

by Zacks Equity Research

Here is how E.ON SE (EONGY) and Exelon (EXC) have performed compared to their sector so far this year.

Zacks Equity Research

Are Transportation Stocks Lagging Euroseas (ESEA) This Year?

by Zacks Equity Research

Here is how Euroseas Ltd. (ESEA) and Westinghouse Air Brake Technologies (WAB) have performed compared to their sector so far this year.

Zacks Equity Research

Is CommVault Systems (CVLT) Stock Outpacing Its Computer and Technology Peers This Year?

by Zacks Equity Research

Here is how Commvault Systems (CVLT) and Calix (CALX) have performed compared to their sector so far this year.

Zacks Equity Research

Is Great Lakes Dredge & Dock (GLDD) Outperforming Other Construction Stocks This Year?

by Zacks Equity Research

Here is how Great Lakes Dredge & Dock (GLDD) and Babcock International Group PLC (BCKIY) have performed compared to their sector so far this year.

Zacks Equity Research

Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?

by Zacks Equity Research

Here is how ANIXA BIOSCIENCES INC (ANIX) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.

Zacks Equity Research

Is Agnico Eagle Mines (AEM) Stock Outpacing Its Basic Materials Peers This Year?

by Zacks Equity Research

Here is how Agnico Eagle Mines (AEM) and Dundee Precious Metals Inc. (DPMLF) have performed compared to their sector so far this year.

Zacks Equity Research

Are Industrial Products Stocks Lagging Allegion (ALLE) This Year?

by Zacks Equity Research

Here is how Allegion (ALLE) and Crown Holdings (CCK) have performed compared to their sector so far this year.

Zacks Equity Research

Are Medical Stocks Lagging DBV Technologies (DBVT) This Year?

by Zacks Equity Research

Here is how DBV Technologies S.A. (DBVT) and Hims & Hers Health, Inc. (HIMS) have performed compared to their sector so far this year.

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A. (DBVT) is a Great Choice

by Zacks Equity Research

Does DBV Technologies S.A. (DBVT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

DBV Technologies (DBVT) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Here's Why Momentum in DBV Technologies (DBVT) Should Keep going

by Zacks Equity Research

DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Here's What Could Help DBV Technologies (DBVT) Maintain Its Recent Price Strength

by Zacks Equity Research

DBV Technologies (DBVT) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks Equity Research

Down -25.23% in 4 Weeks, Here's Why You Should You Buy the Dip in DBV Technologies S.A. (DBVT)

by Zacks Equity Research

DBV Technologies S.A. (DBVT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

BeiGene, Ltd. (BGNE) Surges 12.5%: Is This an Indication of Further Gains?

by Zacks Equity Research

BeiGene, Ltd. (BGNE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

DBV (DBVT) Up as FDA Lifts Partial Hold on Peanut Allergy Study

by Zacks Equity Research

The FDA lifts the partial clinical hold on DBV Technologies' (DVBT) phase III VITESSE study of a modified Viaskin Peanut patch in peanut-allergic children aged four to seven years. Stock rises.

Zacks Equity Research

Kymera Therapeutics, Inc. (KYMR) Moves 9.6% Higher: Will This Strength Last?

by Zacks Equity Research

Kymera Therapeutics, Inc. (KYMR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

DBV Technologies' (DBVT) Peanut Allergy Study on Partial Hold

by Zacks Equity Research

DBV Technologies (DVBT) announces partial hold on phase III study of modified Viaskin Peanut 250 ??g patch, VITESSE, by the FDA. Stock declines.

Zacks Equity Research

Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how DBV Technologies S.A. (DBVT) and ProPhase Labs, Inc. (PRPH) have performed compared to their sector so far this year.

Zacks Equity Research

NGM Biopharmaceuticals (NGM) Soars 6.8%: Is Further Upside Left in the Stock?

by Zacks Equity Research

NGM Biopharmaceuticals (NGM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Is Axonics (AXNX) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Axonics Modulation Technologies (AXNX) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.

Zacks Equity Research

Is Lantheus (LNTH) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Lantheus Holdings (LNTH) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.

Zacks Equity Research

Has DBV Technologies (DBVT) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how DBV Technologies S.A. (DBVT) and Chinook Therapeutics (KDNY) have performed compared to their sector so far this year.